141 related articles for article (PubMed ID: 27647319)
1. Triplet Repeat Primed PCR (TP-PCR) in Molecular Diagnostic Testing for Spinocerebellar Ataxia Type 3 (SCA3).
Melo AR; Ramos A; Kazachkova N; Raposo M; Bettencourt BF; Rendeiro AR; Kay T; Vasconcelos J; Bruges-Armas J; Lima M
Mol Diagn Ther; 2016 Dec; 20(6):617-622. PubMed ID: 27647319
[TBL] [Abstract][Full Text] [Related]
2. An improved polymerase chain reaction method for genetic testing of spinocerebellar ataxia type 3.
Sun WP; He XH; Yu LQ; Wang DP; Qin ZhH; Fang Q; Wang J
Genetika; 2011 Oct; 47(10):1416-9. PubMed ID: 22232931
[TBL] [Abstract][Full Text] [Related]
3. Rapid Molecular Screen of Spinocerebellar Ataxia Types 1, 2, and 3 by Triplet-Primed PCR and Melting Curve Analysis.
Lian M; Zhao M; Phang GP; Soong YT; Yoon CS; Lee CG; Law HY; Chong SS
J Mol Diagn; 2021 May; 23(5):565-576. PubMed ID: 33618058
[TBL] [Abstract][Full Text] [Related]
4. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
5. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and genetic diagnosis of hereditary spinocerebellar ataxia 3.
Wang Y; Yang X; Ma W; Li J; Zhang Q; Xia S; Wang H; Zhang C; Xu X; Zheng J
Mol Med Rep; 2016 Oct; 14(4):3731-4. PubMed ID: 27600091
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of miR-25 and miR-181 Family Members Correlates with Reduced Expression of ATXN3 in Lymphocytes from SCA3 Patients.
Krauss S; Nalavade R; Weber S; Carter K; Evert BO
Microrna; 2019; 8(1):76-85. PubMed ID: 30147021
[TBL] [Abstract][Full Text] [Related]
8. Variation of CAG repeats and two intragenic polymorphisms at SCA3 locus among Machado-Joseph disease/SCA3 patients and diverse normal populations from eastern India.
Chattopadhyay B; Basu P; Gangopadhyay PK; Mukherjee SC; Sinha KK; Chakraborty A; Roy T; Roychoudhury S; Majumder PP; Bhattacharyya NP
Acta Neurol Scand; 2003 Dec; 108(6):407-14. PubMed ID: 14616293
[TBL] [Abstract][Full Text] [Related]
9. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
10. [Detection and analysis of dynamic variant in a pedigree affected with spinocerebellar ataxia type 3].
Chen C; Zhao X; Kong X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1364-1367. PubMed ID: 33306823
[TBL] [Abstract][Full Text] [Related]
11. Autophagy Promoted the Degradation of Mutant ATXN3 in Neurally Differentiated Spinocerebellar Ataxia-3 Human Induced Pluripotent Stem Cells.
Ou Z; Luo M; Niu X; Chen Y; Xie Y; He W; Song B; Xian Y; Fan D; OuYang S; Sun X
Biomed Res Int; 2016; 2016():6701793. PubMed ID: 27847820
[TBL] [Abstract][Full Text] [Related]
12. [Analysis and application of SCA1 and SCA3/MJD gene CAG repeats in Han population in Northeastern China].
Jiang M; Jin CL; Lin CK; Qiu GR; Liu ZL; Wang CX; Sun KL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):83-5. PubMed ID: 14767919
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of MJD1 alleles and molecular analysis of SCA3 patients from Rio de Janeiro, Brazil.
Gestinari RS; Duarte SF; Pimentel MM; Lima MA
Genet Test; 2004; 8(3):281-5. PubMed ID: 15727252
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
15. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
16. Promoter Variation and Expression Levels of Inflammatory Genes IL1A, IL1B, IL6 and TNF in Blood of Spinocerebellar Ataxia Type 3 (SCA3) Patients.
Raposo M; Bettencourt C; Ramos A; Kazachkova N; Vasconcelos J; Kay T; Bruges-Armas J; Lima M
Neuromolecular Med; 2017 Mar; 19(1):41-45. PubMed ID: 27246313
[TBL] [Abstract][Full Text] [Related]
17. Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.
Li X; Liu H; Fischhaber PL; Tang TS
Prog Neurobiol; 2015 Sep; 132():34-58. PubMed ID: 26123252
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with Intergenerational Instability of ATXN3 CAG Repeat and Genetic Anticipation in Chinese Patients with Spinocerebellar Ataxia Type 3.
Du YC; Ma Y; Shao YR; Gan SR; Dong Y; Wu ZY
Cerebellum; 2020 Dec; 19(6):902-906. PubMed ID: 32676850
[TBL] [Abstract][Full Text] [Related]
19. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
20. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
